CNCEC(SH:601117)2020-10-30 16:00Financial Performance - Net profit attributable to shareholders rose by 13.44% to CNY 2.77 billion for the year-to-date period[4] - Operating revenue for the year-to-date period increased by 4.94% to CNY 66.04 billion compared to the same period last year[4] - Basic earnings per share increased by 12.00% to CNY 0.56[4] - The weighted average return on equity improved by 1.15 percentage points to 8.40%[4] - Total revenue for Q3 2020 reached ¥29.63 billion, a 21.5% increase from ¥24.41 billion in Q3 2019[23] - Net profit for Q3 2020 was ¥1.34 billion, up 49.5% from ¥0.89 billion in Q3 2019[24] - The net profit attributable to the parent company for Q3 2020 was approximately CNY 1.33 billion, an increase from CNY 843 million in Q3 2019, representing a growth of 57.7%[25] - The total comprehensive income for Q3 2020 reached approximately CNY 1.26 billion, compared to CNY 911 million in Q3 2019, marking a year-over-year increase of 38.7%[26] - The net profit for the first three quarters of 2020 was approximately CNY 2.25 billion, compared to CNY 1.78 billion in the same period of 2019, reflecting a year-over-year increase of 26.4%[29] - The total comprehensive income for the first three quarters of 2020 was approximately CNY 2.25 billion, compared to CNY 1.78 billion in the same period of 2019, indicating a growth of 26.4%[29] Assets and Liabilities - Total assets increased by 9.20% to CNY 126.53 billion compared to the end of the previous year[4] - The total current assets increased to CNY 100.07 billion, up from CNY 87.79 billion, indicating overall growth in asset base[15] - Total liabilities increased to ¥87.39 billion from ¥78.27 billion, reflecting a growth of around 11.4%[18] - Current liabilities rose to ¥77.67 billion, compared to ¥70.05 billion in the previous year, indicating an increase of approximately 10.4%[18] - Non-current assets decreased to ¥26.46 billion from ¥28.08 billion, a decline of about 5.8% year-over-year[18] - The company reported a significant increase in contract liabilities, reaching ¥20.89 billion, with no prior year comparison available[20] - Total equity attributable to shareholders increased to ¥36.88 billion from ¥35.14 billion, reflecting a growth of about 5%[18] Cash Flow - Net cash flow from operating activities decreased by 36.12% to CNY 1.06 billion for the year-to-date period[4] - Cash inflow from investment activities totaled CNY 3.02 billion, significantly higher than CNY 918.55 million in the same period of 2019, marking an increase of approximately 229.5%[32] - The net cash flow from investment activities was negative at CNY 499.91 million, an improvement from a loss of CNY 3.06 billion in the previous year[32] - Cash inflow from financing activities was CNY 3.44 billion, down from CNY 5.64 billion in 2019, reflecting a decrease of about 39.0%[32] - The total cash and cash equivalents at the end of the period increased to CNY 31.53 billion, up from CNY 25.16 billion in the previous year, representing a growth of approximately 25.3%[32] - The cash received from sales of goods and services was CNY 64.11 billion, compared to CNY 55.17 billion in the same period of 2019, reflecting an increase of approximately 16.2%[31] Shareholder Information - The total number of shareholders at the end of the reporting period was 103,316[6] - The largest shareholder, China Chemical Engineering Group Corporation, holds 37.08% of the shares[6] Operational Metrics - New contracts signed amounted to CNY 146.93 billion, up 27.84% compared to the same period last year, with domestic contracts at CNY 116.47 billion and overseas contracts at CNY 30.46 billion[12] - Accounts receivable increased to CNY 22.74 billion, up from CNY 22.12 billion, reflecting a growth of 2.82%[15] - Inventory decreased significantly to CNY 4.18 billion, down 71.30% from CNY 14.58 billion, primarily due to reclassification under new revenue standards[15] - The company's financial expenses decreased significantly, with a reduction of CNY 95 million, primarily due to exchange rate fluctuations[11] Research and Development - Research and development expenses for Q3 2020 were ¥1.02 billion, an increase of 27.5% compared to ¥0.80 billion in Q3 2019[23] Strategic Developments - The company has not disclosed any significant new strategies or product developments in this report[9]